Table 2—

Phospholipid composition of bronchoalveolar lavage fluid (BALF) and fatty acid profiles of phosphatidylcholine#

ARDS patientsControlAlveofact®
3 h pre15–18 h post72 h post
Subjects n272522123
PC %72.3±2.185.7±0.9***83.5±1.0***83.1±0.982.1±0.9
PG %3.2±0.68.1±0.7***6.9±0.9***8.6±0.69.0±0.8
PI %7.6±1.01.7±0.2***2.7±0.3***3.2±0.20.5±0.2
SPH %9.4±1.21.9±0.2***3.2±0.3***0.8±0.21.4±0.2
PE %5.1±0.82.0±0.3***2.4±0.3***1.7±0.23.0±0.1
PS %1.8±0.60.5±0.2***1.2±0.31.2±0.30.0
14:0 PC BALF %1.56±0.733.22±0.333.78±0.28*3.94±0.633.65±0.08
16:0 PC BALF %59.92±5.7765.98±1.0167.55±2.0472.31±1.3573.45±0.69
18:0 PC BALF %5.34±3.284.35±0.454.24±0.536.74±1.024.34±0.02
18:1 PC BALF %19.39±2.1120.59±0.91*16.71±1.369.66±0.4315.47±0.50
18:2 PC BALF %9.34±2.293.01±0.483.28±0.49**3.95±0.291.42±0.07
  • Data are presented as mean±sem

  • PC: phosphatidylcholine

  • PG: phosphatidylglycerol

  • PI: phosphatidylinositol

  • SPH: sphingomyelin

  • PE: phosphatidylethanolamine

  • PS: phosphatidylserine

  • #: Original lavage fluids were analysed in acute respiratory distress syndrome (ARDS) patients (pre- and postsurfactant administration) and in healthy controls. In addition, the bovine surfactant preparation (Alveofact®) was studied. Depicted is the relative content of each phospholipid class in percent of all phospholipids

  • 14:0: myristic acid

  • 16:0: palmitic acid

  • 18:0: stearic acid

  • 18:1: oleic acid

  • 18:2: linoleic acid

  • Lyso-phosphatidylcholine and cardiolipin were found as trace amounts. The relative content of each fatty acid is given in per cent of all fatty acids analysed in PC isolated from original lavage fluid (BALF). Fatty acids with a relative distribution <0.5% are not given

  • *: p<0.05

  • **: p<0.01

  • ***: p<0.001 as compared to baseline values (3 h pre)